33
/it/
AIzaSyB4mHJ5NPEv-XzF7P6NDYXjlkCWaeKw5bc
November 1, 2025
3512564
319423
2
Public Timelines
FAQ Ricevere il Premium

1 gen 2014 anni - Pembrolizumab

Descrizione:

Pembrolizumab is approved for advanced melanoma treatment by the FDA. This monoclonal antibody blocks a protein called PD1's activity on immune cells, which increases the strength of the immune response to cancer.

Aggiunto al nastro di tempo:

14 nov 2019
0
0
300

Data:

1 gen 2014 anni
Adesso
~ 11 years ago